Pathogenesis of HIV-Associated Non-Hodgkin Lymphoma
Journal:
Current HIV Research
Volume:
2
Page:
215-221
Author(s):
Deirdre Killebrew and Bruce Shiramizu
Immune Restoration Disease: A Consequence of Dysregulated Immune Responses After HAART
Journal:
Current HIV Research
Volume:
2
Page:
235-242
Author(s):
Shelley F. Stone, Patricia Price and Martyn A. French
Chromosomal Aberrations and Genomic Instability Induced by Topoisomerase- Targeted Antitumour Drugs
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
317-325
Author(s):
Francesca Degrassi, Mario Fiore and Fabrizio Palitti
Effect of Prostaglandins on the Regulation of Tumor Growth
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
379-387
Author(s):
Shunji Ishihara, M A.K. Rumi, Toshihiko Okuyama and Yoshikazu Kinoshita
Cytochrome P450 Gene Polymorphism and Cancer
Journal:
Current Drug Metabolism
Volume:
5
Page:
211-224
Author(s):
Jose A.G. Agundez
Flt3 Receptor Tyrosine Kinase as a Drug Target in Leukemia
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1867-1883
Author(s):
Dirk Schmidt-Arras, Joachim Schwable, Frank- D. Bohmer and Hubert Serve
The Role of Protein Kinase C-alpha (PKC-α) in Cancer and its Modulation by the Novel PKC-α-Specific Inhibitor Aprinocarsen
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1923-1936
Author(s):
A- R. Hanauske, Karen Sundell and Michael Lahn
Monitoring Therapy with Gene Expression Profiling Reveals Physiological Differences in Drug Action
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1959-1968
Author(s):
S. Wolfl, A. Burchert and T. C. Kroll
Tumor Intracellular Redox Status and Drug Resistance-Serendipity or a Causal Relationship?
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1969-1977
Author(s):
Shazib Pervaiz and Marie-Veronique Clement
SRC: Regulation, Role in Human Carcinogenesis and Pharmacological Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1745-1756
Author(s):
A. Y. Tsygankov and S. K. Shore